Screening the Silk Road: Q4 2021 High-Risk Names to Avoid
As we move through into Q1 2022, we expect to see volatility around highly priced & leveraged names. This screen is a key starting point towards...
Screening the Silk Road: Q3 2021 High-Risk Names to Avoid
Screening the Silk Road Q3 2021: Asia Pac High-risk names to avoid screening is out now. Eight new names, despite being down 23%, SoftBank remains...
No more insights